You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

CISPPEME+NIVL+IPIL

Cancer Type: Lung, Non-Small Cell      Intent: Palliative
Regimen Category: Evidence-informed
Drugs Used:
nivolumab (Compassionate),
ipilimumab (Compassionate),
Funding:
New Drug Funding Program
    Pemetrexed - Combination with Platinum for Non-Small Cell Lung Cancer

You might also be interested in